2026-10-26 17:35:00 UTC#516373newconfirmednews
MEDP stock news
MEDP stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items
2026-10-23 18:00:00 UTC#508347newconfirmednews
Truist Securities maintains Hold rating on Medpace Holdings
2026-10-23 13:44:00 UTC#507006newconfirmednews
Barclays maintains Medpace Holdings at Equal-Weight, raises price target to $675 from $625
2026-10-23 13:36:00 UTC#506956duplicateconfirmednews
TD Cowen maintains Hold rating on Medpace Holdings, raises price target to $673 from $492
2026-10-23 13:26:09 UTC#506923newconfirmednews
TD Cowen maintains Hold rating on Medpace Holdings, sets $673 price target
2026-10-22 20:03:33 UTC#502519updateconfirmednews
Medpace Q3 EPS $4.84, backlog $3.17B; board authorizes new $1B share repurchase program
2026-10-22 15:48:08 UTC#501131updateconfirmednews
Medpace issues 2026 EPS guidance of $17.97-$18.32 and authorizes new $1B share repurchase program
2026-10-22 14:32:29 UTC#500742duplicateconfirmednews
Medpace Q3 revenue up 8.5% with record awards and raised FY2026 guidance
2026-10-22 12:57:03 UTC#500182newconfirmednews
Medpace Holdings, Inc. Q3 2026 earnings call commences
2026-10-22 03:05:17 UTC#497145newconfirmednews
Medpace Q3 revenue up 8.5%, EBITDA up 16.0%; FY2026 guidance raised on higher awards and backlog
2026-10-21 22:05:53 UTC#496276updateconfirmednews
Medpace Holdings raises 2026 EPS guidance range following Q3 earnings beat
2026-10-21 21:03:00 UTC#495987newconfirmedpress release
Medpace Holdings authorizes new $1 billion stock repurchase program
2026-10-21 20:19:54 UTC#495581newconfirmeddata release
Medpace Q3 2026 GAAP EPS $4.84 beats by $0.41, Revenue $716M beats by $1.56M
2026-10-07 18:24:00 UTC#427644newconfirmednews
Mizuho maintains Outperform rating on Medpace Holdings (MEDP)
2026-10-07 15:12:00 UTC#426646newconfirmednews
Barclays maintains Equal-Weight rating on Medpace Holdings (MEDP)
2026-10-01 21:50:01 UTC#402105newconfirmednews
Medpace CEO August J. Troendle sells $30.3M in common stock via SEC filings
tradingviewimportance 0.40trust 0.90Medpace Holdings, Inc. -0.20August J. Troendle -0.20Medpace Investors, LLC 0
2026-09-21 20:30:01 UTC#345063newconfirmednews
Medpace Holdings CEO August J. Troendle sells $6.75M in company stock per SEC filing
tradingviewimportance 0.30trust 0.90Medpace Holdings, Inc. -0.20August J. Troendle -0.20Medpace Investors, LLC 0
2026-09-17 20:40:01 UTC#329959newconfirmednews
Medpace CEO August J. Troendle sells $15.36M in common stock via SEC filings
tradingviewimportance 0.30trust 0.90Medpace Holdings, Inc. -0.20August J. Troendle -0.20Medpace Investors, LLC 0
2026-08-28 20:40:01 UTC#237255newconfirmednews
Medpace Director Robert O. Kraft sells $2.38M in common stock per SEC filing
2026-08-25 20:30:01 UTC#219517newconfirmednews
Medpace CEO August J. Troendle sells $9.97M in company stock via SEC filing
tradingviewimportance 0.30trust 0.90Medpace Holdings, Inc. -0.20August J. Troendle -0.20Medpace Investors, LLC 0